We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVOP
2151
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.18M | ﹤0.01% |
49,740
+2,201
| +5% | +$58.5K |
|
2152
Manitowoc
MTW
$675M
| $1.18M | ﹤0.01% |
54,934
+1,397
| +3% | +$32.3K |
|
2153
Ranpak Holdings
PACK
$473M
| $1.18M | ﹤0.01% |
43,824
+2,260
| +5% | +$63.5K |
|
2154
Smith & Wesson
SWBI
$637M
| $1.17M | ﹤0.01% |
56,537
-800
| -1% | -$19.2K |
|
2155
American Vanguard Corp
AVD
$68.9M
| $1.17M | ﹤0.01% |
77,970
-10,259
| -12% | -$162K |
|
|
LGF.A
2156
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.17M | ﹤0.01% |
82,438
+2,217
| +3% | +$32.4K |
|
2157
Weis Markets
WMK
$1.86B
| $1.16M | ﹤0.01% |
22,156
-5,066
| -19% | -$275K |
|
2158
Driven Brands
DRVN
$2.2B
| $1.16M | ﹤0.01% |
40,033
+5,569
| +16% | +$165K |
|
2159
Marcus Corp
MCS
$945M
| $1.16M | ﹤0.01% |
66,290
-11,656
| -15% | -$190K |
|
|
RAD
2160
DELISTED
Rite Aid Corporation
RAD
| $1.15M | ﹤0.01% |
81,190
-1,461
| -2% | -$23K |
|
|
MORF
2161
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.15M | ﹤0.01% |
20,320
+834
| +4% | +$50.5K |
|
2162
Columbia Financial
CLBK
$1.13B
| $1.15M | ﹤0.01% |
61,880
+911
| +1% | +$16.3K |
|
|
TSP
2163
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.15M | ﹤0.01% |
30,844
-1,372
| -4% | -$57.8K |
|
|
MCFE
2164
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $1.14M | ﹤0.01% |
51,503
+8,651
| +20% | +$224K |
|
2165
Gossamer Bio
GOSS
$87M
| $1.14M | ﹤0.01% |
90,547
+3,223
| +4% | +$29.7K |
|
|
GBIO
2166
DELISTED
Generation Bio
GBIO
| $1.13M | ﹤0.01% |
4,511
+197
| +5% | +$47.2K |
|
2167
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $1.13M | ﹤0.01% |
42,607
+1,700
| +4% | +$44.7K |
|
2168
Ezcorp Inc
EZPW
$1.71B
| $1.13M | ﹤0.01% |
148,621
-19,845
| -12% | -$127K |
|
2169
Krystal Biotech
KRYS
$9.66B
| $1.13M | ﹤0.01% |
21,544
+860
| +4% | +$50.9K |
|
2170
Horizon Bancorp
HBNC
$1.04B
| $1.12M | ﹤0.01% |
61,800
+1,325
| +2% | +$22.9K |
|
2171
Heron Therapeutics
HRTX
$92.9M
| $1.12M | ﹤0.01% |
105,039
+4,210
| +4% | +$51.3K |
|
2172
Orion
OEC
$409M
| $1.12M | ﹤0.01% |
61,622
+2,135
| +4% | +$38.2K |
|
2173
ADT
ADT
$5.58B
| $1.12M | ﹤0.01% |
138,731
-10,459
| -7% | -$96.4K |
|
|
WOW
2174
DELISTED
WideOpenWest
WOW
| $1.12M | ﹤0.01% |
56,946
+3,825
| +7% | +$80.2K |
|
2175
QCR Holdings
QCRH
$1.7B
| $1.12M | ﹤0.01% |
21,734
+500
| +2% | +$24.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.